319 related articles for article (PubMed ID: 32293530)
41. Circulating IFN-γ producing CD4+ T cells and IL-17A producing CD4+ T cells, HLA-shared epitope and ACPA may characterize the clinical response to therapy in rheumatoid arthritis patients.
Alvandpur N; Tabatabaei R; Tahamoli-Roudsari A; Basiri Z; Behzad M; Rezaeepoor M; Roshanaei G; Hajilooi M; Solgi G
Hum Immunol; 2020 May; 81(5):228-236. PubMed ID: 32107036
[TBL] [Abstract][Full Text] [Related]
42. Anti-cyclic citrullinated peptide antibodies are associated with radiographic damage but not disease activity in early rheumatoid arthritis diagnosed in 2006-2011.
Ziegelasch M; Boman A; Martinsson K; Thyberg I; Jacobs C; Nyhäll-Wåhlin BM; Svärd A; Berglin E; Rantapää-Dahlqvist S; Skogh T; Kastbom A
Scand J Rheumatol; 2020 Nov; 49(6):434-442. PubMed ID: 32856532
[No Abstract] [Full Text] [Related]
43. CTHRC1: A New Candidate Biomarker for Improved Rheumatoid Arthritis Diagnosis.
Myngbay A; Bexeitov Y; Adilbayeva A; Assylbekov Z; Yevstratenko BP; Aitzhanova RM; Matkarimov B; Adarichev VA; Kunz J
Front Immunol; 2019; 10():1353. PubMed ID: 31249576
[No Abstract] [Full Text] [Related]
44. Clinical Significance of Red Blood Cell Distribution Width and Inflammatory Factors for the Disease Activity in Rheumatoid Arthritis.
Yunchun L; Yue W; Jun FZ; Qizhu S; Liumei D
Clin Lab; 2016 Dec; 62(12):2327-2331. PubMed ID: 28164544
[TBL] [Abstract][Full Text] [Related]
45. Alveolar bone loss is associated with circulating anti-citrullinated protein antibody (ACPA) in patients with rheumatoid arthritis.
Gonzalez SM; Payne JB; Yu F; Thiele GM; Erickson AR; Johnson PG; Schmid MJ; Cannon GW; Kerr GS; Reimold AM; Sokolove J; Robinson WH; Mikuls TR
J Periodontol; 2015 Feb; 86(2):222-31. PubMed ID: 25299390
[TBL] [Abstract][Full Text] [Related]
46. Serum IgG ACPA-IgM RF immune complexes were detected in rheumatoid arthritis patients positive for IgM ACPA.
Haraguchi A; Yamada H; Kondo M; Okazaki K; Fukushi JI; Oyamada A; Yoshikai Y; Nakashima Y
Clin Exp Rheumatol; 2018; 36(4):612-618. PubMed ID: 29465353
[TBL] [Abstract][Full Text] [Related]
47. Specific Association of HLA-DRB1*03 With Anti-Carbamylated Protein Antibodies in Patients With Rheumatoid Arthritis.
Regueiro C; Rodriguez-Rodriguez L; Triguero-Martinez A; Nuño L; Castaño-Nuñez AL; Villalva A; Perez-Pampin E; Lopez-Golan Y; Abasolo L; Ortiz AM; Herranz E; Pascual-Salcedo D; Martínez-Feito A; Boveda MD; Gomez-Reino JJ; Martín J; Gonzalez-Escribano MF; Fernandez-Gutierrez B; Balsa A; Gonzalez-Alvaro I; Gonzalez A
Arthritis Rheumatol; 2019 Mar; 71(3):331-339. PubMed ID: 30277011
[TBL] [Abstract][Full Text] [Related]
48. Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease.
Giles JT; Danoff SK; Sokolove J; Wagner CA; Winchester R; Pappas DA; Siegelman S; Connors G; Robinson WH; Bathon JM
Ann Rheum Dis; 2014 Aug; 73(8):1487-94. PubMed ID: 23716070
[TBL] [Abstract][Full Text] [Related]
49. Identification of Subclinical Lung Involvement in ACPA-Positive Subjects through Functional Assessment and Serum Biomarkers.
Lucchino B; Di Paolo M; Gioia C; Vomero M; Diacinti D; Mollica C; Alessandri C; Diacinti D; Palange P; Di Franco M
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708286
[TBL] [Abstract][Full Text] [Related]
50. Serum anti-citrullinated protein antibodies and rheumatoid factor increase the risk of rheumatoid arthritis-related interstitial lung disease: a meta-analysis.
Xie S; Li S; Chen B; Zhu Q; Xu L; Li F
Clin Rheumatol; 2021 Nov; 40(11):4533-4543. PubMed ID: 34189672
[TBL] [Abstract][Full Text] [Related]
51. ACPA-negative RA consists of subgroups: patients with high likelihood of achieving sustained DMARD-free remission can be identified by serological markers at disease presentation.
Boeters DM; Burgers LE; Sasso EH; Huizinga TWJ; van der Helm-van Mil AHM
Arthritis Res Ther; 2019 May; 21(1):121. PubMed ID: 31088574
[TBL] [Abstract][Full Text] [Related]
52. The role of anti-citrullinated protein antibody reactivities in an inception cohort of patients with rheumatoid arthritis receiving treat-to-target therapy.
Jonsson MK; Hensvold AH; Hansson M; Aga AB; Sexton J; Mathsson-Alm L; Cornillet M; Serre G; Lillegraven S; Fevang BS; Catrina AI; Haavardsholm EA
Arthritis Res Ther; 2018 Jul; 20(1):146. PubMed ID: 30001740
[TBL] [Abstract][Full Text] [Related]
53. Elevated BMI and antibodies to citrullinated proteins interact to increase rheumatoid arthritis risk and shorten time to diagnosis: A nested case-control study of women in the Nurses' Health Studies.
Tedeschi SK; Cui J; Arkema EV; Robinson WH; Sokolove J; Lingampalli N; Sparks JA; Karlson EW; Costenbader KH
Semin Arthritis Rheum; 2017 Jun; 46(6):692-698. PubMed ID: 27939764
[TBL] [Abstract][Full Text] [Related]
54. Elevated levels of anti-carbamylated protein antibody in patients with rheumatoid arthritis: association with disease activity and bone destruction.
Zhang B; Lei Y; Li X; Gao Z; Xia L; Lu J; Shen H
J Investig Med; 2020 Aug; 68(6):1186-1192. PubMed ID: 32690598
[TBL] [Abstract][Full Text] [Related]
55. Longitudinal study of clinical prognostic factors in patients with early rheumatoid arthritis: the PREDICT study.
Bird P; Nicholls D; Barrett R; de Jager J; Griffiths H; Roberts L; Tymms K; McCloud P; Littlejohn G;
Int J Rheum Dis; 2017 Apr; 20(4):460-468. PubMed ID: 28205333
[TBL] [Abstract][Full Text] [Related]
56. Anti-citrullinated protein antibodies are associated with neutrophil extracellular trap formation in rheumatoid arthritis.
Wu S; Peng W; Liang X; Wang W
J Clin Lab Anal; 2021 Mar; 35(3):e23662. PubMed ID: 33249645
[TBL] [Abstract][Full Text] [Related]
57. A retrospective analysis of the relationship between anti-cyclic citrullinated peptide antibody and the effectiveness of abatacept in rheumatoid arthritis patients.
Kida D; Takahashi N; Kaneko A; Hirano Y; Fujibayashi T; Kanayama Y; Hanabayashi M; Yabe Y; Takagi H; Oguchi T; Kato T; Funahashi K; Matsumoto T; Ando M; Kuwatsuka Y; Tanaka E; Yasuoka H; Kaneko Y; Hirata S; Murakami K; Sobue Y; Nishiume T; Suzuki M; Yokota Y; Terabe K; Asai S; Ishiguro N; Kojima T
Sci Rep; 2020 Nov; 10(1):19717. PubMed ID: 33184461
[TBL] [Abstract][Full Text] [Related]
58. Galectin-3 is Persistently Increased in Early Rheumatoid Arthritis (RA) and Associates with Anti-CCP Seropositivity and MRI Bone Lesions, While Early Fibrosis Markers Correlate with Disease Activity.
Issa SF; Christensen AF; Lindegaard HM; Hetland ML; Hørslev-Petersen K; Stengaard-Pedersen K; Ejbjerg BJ; Lottenburger T; Ellingsen T; Pedersen JK; Junker K; Svendsen A; Tarp U; Østergaard M; Junker P
Scand J Immunol; 2017 Dec; 86(6):471-478. PubMed ID: 28990250
[TBL] [Abstract][Full Text] [Related]
59. Clinical Relevance of Galectin-1 and Galectin-3 in Rheumatoid Arthritis Patients: Differential Regulation and Correlation With Disease Activity.
Mendez-Huergo SP; Hockl PF; Stupirski JC; Maller SM; Morosi LG; Pinto NA; Berón AM; Musuruana JL; Nasswetter GG; Cavallasca JA; Rabinovich GA
Front Immunol; 2018; 9():3057. PubMed ID: 30687310
[TBL] [Abstract][Full Text] [Related]
60. Detection of anti-citrullinated protein antibody (ACPA) in saliva for rheumatoid arthritis using DBA mice infected with Porphyromonas gingivalis.
Sakaguchi W; To M; Yamamoto Y; Inaba K; Yakeishi M; Saruta J; Fuchida S; Hamada N; Tsukinoki K
Arch Oral Biol; 2019 Dec; 108():104510. PubMed ID: 31446118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
